OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

Exclusion Criteria

• •Symptoms of OAB due to a neurological reason
• •Use of anticholinergics or other medications or therapies to treat symptoms of OAB within 7 days of screening
• •Use of Clean Intermittent Catheterization (CIC) or indwelling catheter to manage urinary incontinence
• •Use of botulinum toxin therapy of any serotype for any urological condition
• •Use of botulinum toxin therapy of any serotype for any non-urological condition in the 12 weeks prior to screening
• •History of any pelvic or urological abnormalities, bladder surgery or disease, other than OAB, that may affect bladder function
• •Diagnosis of Myasthenia gravis, Eaton-Lambert syndrome, or Amyotrophic Lateral Sclerosis.